Project Grant S10OD036250
- Federal Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded $425,000 to Massachusetts General Hospital under the Research Infrastructure Programs (CFDA 93.351) to acquire a SCANCO nano/microcomputed tomography (microCT) imaging system. This advanced cabinet, cone-beam ultrahigh-resolution system will provide three-dimensional imaging capabilities at voxel sizes ranging from 0.5 to 100 micrometers, accommodating sample sizes up to 105 millimeters in diameter...
- Federal Grant Award Summary The University of Rochester received a $466,325 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to acquire a Bruker Skyscan 1276 CMOS Edition high-resolution in vivo microcomputed tomography (microCT) imaging system. The award, effective May 15, 2026 through May 14, 2027, supports the purchase and deployment of this advanced imaging instrument at the Biomechanics and...
- Federal Project Grant Award Summary Massachusetts General Hospital (MGH) received a $578,070 Project Grant from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) awarded August 1, 2025, with completion targeted for July 1, 2026. The award funds the acquisition and installation of the OmniTom Elite Photon Counting Mobile Computed Tomography (CT) Scanner from NeuroLogica. This compact, self-shielded research instrument will be...
- The National Science Foundation (NSF) Office of Integrative Activities awarded a $1,177,779 Project Grant to the University of Georgia (UGA) Research Foundation to acquire a high-resolution X-ray computed microtomography (micro-CT) imaging system with in situ capabilities. This award, made under the Integrative Activities (CFDA 47.083) program, will support research, training, teaching, and outreach efforts across more than 30 investigators at UGA, Georgia Tech, and Emory University in diverse...
- Oregon Health & Science University (OHSU) received a $742,360 Project Grant award from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) on July 15, 2025, with a completion date of July 14, 2026. The award funds the acquisition of a VEVO F2 LAZR-X dual ultrasound-photoacoustic imaging system (FUJIFILM, VisualSonics) to support in vivo, non-invasive longitudinal imaging of small animal models. This advanced instrumentation...
- Federal Project Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded The Johns Hopkins University $999,928 under the Research Infrastructure Programs (CFDA 93.351) to acquire a high-resolution small animal Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) system equipped with cadmium zinc telluride (CZT) detectors. This High-End Instrumentation grant, effective from July 15, 2025, through July 14, 2026, will support Johns Hopkins'...
- This $341,830 federal Project Grant award from the National Science Foundation (NSF) Integrative Activities program (CFDA 47.083) provides funding to Occidental College to acquire a Rigaku CT Lab HX130 microCT scanner. The microCT scanner will support a wide range of biological research and enable non-destructive sampling for Occidental College's natural history collections, which collectively house over one million specimens. Faculty and students will use the instrument across applications...
- Federal Grant Award Summary Massachusetts General Hospital received a $1,061,520 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) to procure a VisualSonics VEVO F2 LAZR-X20 photoacoustic and ultrasound imaging system. The award, effective May 1, 2026 through April 30, 2027, funds the acquisition of this next-generation multi-modal imaging system to replace the hospital's outdated VEVO 2100 LAZR system...
- Federal Project Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded the University of Southern California $1,131,640 under the Research Infrastructure Programs (CFDA 93.351) on September 19, 2025, to procure and deploy a Leica Stellaris 8 DIVE/FALCON multimodal multiphoton fluorescence microscope system powered by a Chameleon Discovery NX laser. The instrument will be operated and maintained by the Multi-Photon Microscopy Core at the Zilkha Neurogenetic...
- Project Grant Summary Colorado State University received a Project Grant award of $727,297 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 15, 2025, with completion targeted for July 14, 2026. The award funds the acquisition and implementation of a 3i Marianas Super-Resolution Spinning Disk Confocal (SDC) microscope system to replace the university's original open-access SDC microscope...
SKYSCAN 1276 - PROJECT SUMMARY / ABSTRACT HIGH RESOLUTION IN VIVO MICRO-COMPUTED TOMOGRAPHY (MICROCT) IMAGING AND ANALYSIS OF BONE AND OTHER TISSUES (FAT, MUSCLE, CONTRAST-ENHANCED VASCULATURE) HAS BECOME A "GOLD STANDARD" TECHNIQUE IN LONGITUDINAL STUDIES, BUT OUR INSTITUTION CURRENTLY LACKS SUCH AN INSTRUMENT. AUGUSTA UNIVERSITY (AU) HAS MANY NIH-SUPPORTED PROJECTS THAT WOULD BENEFIT FROM THIS HIGH RESOLUTION TOOL, WHICH WOULD ENHANCE THE PRECISION, RIGOR, AND REPRODUCIBILITY OF OUR INVESTIGATORS' FUNDED AND PRELIMINARY STUDIES. OUR FUNCTIONAL OUTCOMES CORE POSSESSES A HIGH-RESOLUTION EX VIVO MICROCT INSTRUMENT THAT IS USED AT MAXIMUM CAPACITY BY INVESTIGATORS STUDYING BONE, TEETH, AND VASCULATURE IN ISOLATED TISSUE SAMPLES, AND A LOWER RESOLUTION IN VIVO DXA INSTRUMENT USED HEAVILY BY INVESTIGATORS STUDYING BONE DENSITY AND BODY COMPOSITION. IN THIS PROPOSAL, A GROUP OF DIVERSE INVESTIGATORS WITH WELL-ESTABLISHED RESEARCH PROGRAMS AND ACTIVE NIH SUPPORT HAVE DOCUMENTED THEIR NEED FOR THE NEW, HIGH- RESOLUTION MICROCT SYSTEM, PARTICULARLY A MACHINE WITH NOVEL IN VIVO CAPABILITIES COMPARED TO THE EX VIVO MICROCT SCANNER CURRENTLY USED. THE FUNCTIONAL OUTCOMES CORE AT AU, WHICH RUNS THE EXISTING EX VIVO MICROCT AND DXA INSTRUMENTATION, HAS EXTENSIVE SCIENTIFIC, TECHNICAL, AND ADMINISTRATIVE EXPERIENCE WITH IN VIVO AND EX VIVO IMAGING TECHNOLOGY, INCLUDING MICROCT. OVER THE PAST DECADE, THIS CORE HAS ESTABLISHED AN EXCEPTIONAL NATIONAL AND INTERNATIONAL REPUTATION FOR TECHNICAL EFFICIENCY AND SCIENTIFIC INTEGRITY, REFLECTED BY THE NUMBER OF MANUSCRIPTS PUBLISHED IN REPUTABLE JOURNALS AND SUCCESSFUL GRANT AWARDS. THE COLLECTIVE EXPERTISE IN MICROCT TECHNOLOGY AT AU WILL ENSURE THAT THE NEW IN VIVO MICROCT SYSTEM WILL BE UTILIZED TO ITS FULL POTENTIAL AND WELL MAINTAINED. THE NEW SYSTEM WILL ALSO PROVIDE CRITICAL SUPPORT TO EARLY STAGE INVESTIGATORS AT AU, AS WELL AS CATALYZE MORE COLLABORATIONS AND SERVE AS AN ATTRACTIVE FEATURE FOR RECRUITING NEW FACULTY. THE ADMINISTRATION AT AU IS FULLY IN SUPPORT THE PROPOSAL AND HAS AGREED TO SUPPORT THE ANNUAL SERVICE CONTRACT FOR THE MACHINE; FULL SUPPORT FOR A TECHNICIAN'S TIME WILL BE PROVIDED BY AN ACTIVE PROGRAM PROJECT GRANT (PPG) AWARD AND THE INSTITUTION. HOWEVER, DUE TO STRICT INSTITUTIONAL BUDGETARY LIMITATIONS, INTERNAL RESOURCES WILL NOT ALLOW THE PURCHASE OF A NEW MACHINE WITHOUT THIS FUNDING MECHANISM. IN SUMMARY, THERE IS A CRITICAL NEED FOR THIS IN VIVO MICROCT TECHNOLOGY ON OUR CAMPUS, AND THE ONLY WAY TO ACQUIRE IT IS THROUGH THE S10 MECHANISM. THE NEW MACHINE WILL PERMIT LONGITUDINAL, HIGH RESOLUTION, IN VIVO, 3D, SITE-SPECIFIC ANALYSES OF MINERALIZED AND SOFT TISSUES THAT CANNOT BE PERFORMED WITH EXISTING INSTRUMENTS. PROCUREMENT OF AN IN VIVO MICROCT WILL ENHANCE THE RIGOR OF ONGOING EXPERIMENTS FROM A SUBSTANTIAL NUMBER OF OUR INSTITUTION'S NIH-FUNDED INVESTIGATORS AND REDUCE OUR INVESTIGATORS' NEEDS FOR VERTEBRATE ANIMALS IN THEIR EXPERIMENTS. OUR CORE HAS EXTENSIVE EXPERTISE IN THE TECHNOLOGY AND HAS DEVELOPED A ROBUST ADMINISTRATIVE STRUCTURE AND OVERSIGHT FOR THE USAGE OF THIS NEW INSTRUMENT. OUR INSTITUTION IS IN FULL SUPPORT OF THIS AWARD. COLLECTIVELY, THIS AWARD WILL BE A WORTHWHILE INVESTMENT THAT SERVES THE MISSION OF THE NIH.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | 0$ | 9/18/25 | ||
| Not listed | $120.0k | 7/19/24 | ||
| Not listed | $394.8k | 6/6/24 | ||
| Not listed | $394.8k | 6/6/24 |